Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01265797 · ClinicalTrials.gov registry record · NA
Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches
A NA study, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01265797: Completed NA study, sponsored by University of Toledo Health Science Campus.
NCT01265797 is a NA study that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01265797, a NA study, has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.
Primary Outcome
Mean change in headache days between 28 day run-in month and 28 day blinded month, i.e. run-in month mean minus blinded month mean. A good response is \>= 50% reduction in headache days (congruent with the Guidelines for Trial of Behavioral Treatments for Recurrent Headache).
Interventions
- DEVICE Sham Device
- DEVICE Cranial Electrostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01265797 record still lists
NCT01265797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Device is the first listed.
NCT01265797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01265797 about?
NCT01265797 is a clinical study titled "Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches". Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.
What is the current status of trial NCT01265797?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2011-12. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01265797?
The interventions under investigation include: Sham Device (DEVICE), Cranial Electrostimulator (DEVICE).
Who is sponsoring clinical trial NCT01265797?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01265797's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia